Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vivian W Y Liao

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Frontiers in Neuroscience|December 17, 2020
The Z-Drugs Zolpidem, Zaleplon, and Eszopiclone Have Varying Actions on Human GABA <sub></sub> Receptors Containing γ1, γ2, and γ3 SubunitsGrant Richter, Vivian W Y Liao, Philip K Ahring, et al.
Journal of Biochemistry|April 11, 2023
3,5-bis(styryl)pyrazole inhibits mitosis and induces cell death independent of BubR1 and p53 levels by depolymerizing microtubulesPooja J Batra, Anuradha Kumari, Vivian W Y Liao, et al.
Molecular Pharmacology|April 4, 2020
Tubulin-Binding 3,5-Bis(styryl)pyrazoles as Lead Compounds for the Treatment of Castration-Resistant Prostate CancerVivian W Y Liao, Anuradha Kumari, Rajeshwar Narlawar, et al.
Brain : a Journal of Neurology|August 30, 2023
Correlations of receptor desensitization of gain-of-function GABRB3 variants with clinical severitySusan X N Lin, Philip K Ahring, Angelo Keramidas, et al.
Journal of Neurochemistry|August 25, 2023
GABA<sub>A</sub> receptors in epilepsy: Elucidating phenotypic divergence through functional analysis of genetic variantsNathan L Absalom, Susan X N Lin, Vivian W Y Liao, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|June 10, 2017
The Synthesis and Evaluation of Fluoro-, Trifluoromethyl-, and Iodomuscimols as GABA AgonistsMohd Abdul Fatah Abdul Manan, David B Cordes, Alexandra M Z Slawin, et al.
British Journal of Pharmacology|April 19, 2018
Galantamine is not a positive allosteric modulator of human α4β2 or α7 nicotinic acetylcholine receptorsNatalia M Kowal, Philip K Ahring, Vivian W Y Liao, et al.
Annals of Clinical and Translational Neurology|July 12, 2023
Vinpocetine improved neuropsychiatric and epileptic outcomes in a patient with a GABRA1 loss-of-function variantCathrine E Gjerulfsen, Tomasz S Mieszczanek, Katrine M Johannesen, et al.
Bioorganic & Medicinal Chemistry|December 1, 2015
Identification of dual PPARα/γ agonists and their effects on lipid metabolismQuanqing Gao, Jacky Hanh, Linda Váradi, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 6, 2024
Understanding paralogous epilepsy-associated GABA<sub>A</sub> receptor variants: Clinical implications, mechanisms, and potential pitfallsAnthony S H Kan, Ali S Kusay, Nazanin A Mohammadi, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Frontiers in Neuroscience|December 17, 2020
The Z-Drugs Zolpidem, Zaleplon, and Eszopiclone Have Varying Actions on Human GABA <sub></sub> Receptors Containing γ1, γ2, and γ3 SubunitsGrant Richter, Vivian W Y Liao, Philip K Ahring, et al.
Journal of Biochemistry|April 11, 2023
3,5-bis(styryl)pyrazole inhibits mitosis and induces cell death independent of BubR1 and p53 levels by depolymerizing microtubulesPooja J Batra, Anuradha Kumari, Vivian W Y Liao, et al.
Molecular Pharmacology|April 4, 2020
Tubulin-Binding 3,5-Bis(styryl)pyrazoles as Lead Compounds for the Treatment of Castration-Resistant Prostate CancerVivian W Y Liao, Anuradha Kumari, Rajeshwar Narlawar, et al.
Brain : a Journal of Neurology|August 30, 2023
Correlations of receptor desensitization of gain-of-function GABRB3 variants with clinical severitySusan X N Lin, Philip K Ahring, Angelo Keramidas, et al.
Journal of Neurochemistry|August 25, 2023
GABA<sub>A</sub> receptors in epilepsy: Elucidating phenotypic divergence through functional analysis of genetic variantsNathan L Absalom, Susan X N Lin, Vivian W Y Liao, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|June 10, 2017
The Synthesis and Evaluation of Fluoro-, Trifluoromethyl-, and Iodomuscimols as GABA AgonistsMohd Abdul Fatah Abdul Manan, David B Cordes, Alexandra M Z Slawin, et al.
British Journal of Pharmacology|April 19, 2018
Galantamine is not a positive allosteric modulator of human α4β2 or α7 nicotinic acetylcholine receptorsNatalia M Kowal, Philip K Ahring, Vivian W Y Liao, et al.
Annals of Clinical and Translational Neurology|July 12, 2023
Vinpocetine improved neuropsychiatric and epileptic outcomes in a patient with a GABRA1 loss-of-function variantCathrine E Gjerulfsen, Tomasz S Mieszczanek, Katrine M Johannesen, et al.
Bioorganic & Medicinal Chemistry|December 1, 2015
Identification of dual PPARα/γ agonists and their effects on lipid metabolismQuanqing Gao, Jacky Hanh, Linda Váradi, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 6, 2024
Understanding paralogous epilepsy-associated GABA<sub>A</sub> receptor variants: Clinical implications, mechanisms, and potential pitfallsAnthony S H Kan, Ali S Kusay, Nazanin A Mohammadi, et al.
Pageof 2